Elray Resources, Inc. sold $9.3M of FRMM
other at 180 Life Sciences Corp.. 2,998,000 shares at an average of $3.09, traded Jul 27, 2025, filed Aug 18, 2025.
Score components
- +8RoleOther
- +25Trade size$9.3M at market
- +20Share of holdings soldSold 69% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -69.1%, 3m -83.3%, 6m -95.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001477932-25-006027, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 27, 2025 | XIn-the-money exercise Common Stock | +3,000,000 | $1.68 | $5.0M | 4,318,000 | Aug 18, 2025 |
| Jul 27, 2025 | SOpen-market sale Common Stock | -1,680,000 | $3.00 | $5.0M | 2,638,000 | Aug 18, 2025 |
| Aug 7, 2025 | SOpen-market sale Common Stock | -135,257 | $3.56 | $482k | 2,502,743 | Aug 18, 2025 |
| Aug 8, 2025 | SOpen-market sale Common Stock | -777,595 | $3.18 | $2.5M | 1,725,148 | Aug 18, 2025 |
| Aug 11, 2025 | SOpen-market sale Common Stock | -405,148 | $3.17 | $1.3M | 1,320,000 | Aug 18, 2025 |
| Jul 27, 2025 | XIn-the-money exercise Common Stock Purchase Warrantsderivative | -3,000,000 | $0.00 | $0 | 0 | Aug 18, 2025 |
Related signals
Other insiders at 180 Life Sciences Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | FRMMsell 180 Life Sciences Corp. | Konstantin Lomashuk owner | $1.5M 250,000 shares | -17% | |
| 12Weak | FRMMsell 180 Life Sciences Corp. | Konstantin Lomashuk owner | $16k 2,562 shares | -0% | |
| 12Weak | FRMMsell 180 Life Sciences Corp. | Konstantin Lomashuk owner | $21k 3,387 shares | -0% | |
| 17Weak | FRMMsell 180 Life Sciences Corp. | Konstantin Lomashuk owner | $30k 4,802 shares | -0% | |
| 53Moderate | FRMMbuy 180 Life Sciences Corp. | James N. Woody Chief Executive Officer | $4,700 25,000 shares | +60% | |
| 20Weak | FRMMsell 180 Life Sciences Corp. | Marc Feldmann director | $4,700 25,000 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.